Related Experiment Video
Updated: Apr 4, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois1, Helen Loo Yau2, Rajat Singhania1
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
Abstract:
DNA-demethylating agents have shown clinical anti-tumor efficacy via an unknown mechanism of action. Using a combination of experimental and bioinformatics analyses in colorectal cancer cells, we demonstrate that low-dose 5-AZA-CdR targets colorectal cancer-initiating cells (CICs) by inducing viral mimicry. This is associated with induction of dsRNAs derived at least in part from endogenous retroviral elements, activation of the MDA5/MAVS RNA recognition pathway, and downstream activation of IRF7. Indeed, disruption of virus recognition pathways, by individually knocking down MDA5, MAVS, or IRF7, inhibits the ability of 5-AZA-CdR to target colorectal CICs and significantly decreases 5-AZA-CdR long-term growth effects. Moreover, transfection of dsRNA into CICs can mimic the effects of 5-AZA-CdR. Together, our results represent a major shift in understanding the anti-tumor mechanisms of DNA-demethylating agents and highlight the MDA5/MAVS/IRF7 pathway as a potentially druggable target against CICs.
Insights
Low-dose 5-AZA-CdR targets colorectal cancer-initiating cells (CICs) by inducing viral mimicry. This activates the MDA5/MAVS/IRF7 pathway, offering a new therapeutic strategy for colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- DNA-demethylating agents show anti-tumor effects through unclear mechanisms.
- Colorectal cancer-initiating cells (CICs) are crucial for tumor growth and recurrence.
Purpose of the Study:
- To elucidate the mechanism of action for low-dose 5-AZA-CdR in colorectal cancer.
- To investigate the role of viral mimicry and RNA recognition pathways in 5-AZA-CdR efficacy.
Main Methods:
- Experimental and bioinformatics analyses in colorectal cancer cells.
- Investigated the effects of 5-AZA-CdR on CICs, dsRNA induction, and the MDA5/MAVS/IRF7 pathway.
- Disruption of key pathway components (MDA5, MAVS, IRF7) and dsRNA transfection experiments.
Main Results:
- Low-dose 5-AZA-CdR induces viral mimicry in colorectal CICs.
- This involves dsRNA production from endogenous retroviral elements, activating the MDA5/MAVS/IRF7 pathway.
- Disrupting this pathway abrogates 5-AZA-CdR's targeting of CICs and its long-term growth inhibition.
Conclusions:
- The anti-tumor mechanism of DNA-demethylating agents involves inducing viral mimicry and activating the MDA5/MAVS/IRF7 pathway.
- This pathway is critical for 5-AZA-CdR's efficacy against colorectal CICs.
- The MDA5/MAVS/IRF7 pathway represents a potential therapeutic target for colorectal cancer treatment.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Bacterial DNA Synthesis
Induced Pluripotent Stem Cells
Somatic...
MicroRNAs
Viruses with RNA Genomes

